| Evolving concepts of asthma M Gauthier, A Ray, SE Wenzel American journal of respiratory and critical care medicine 192 (6), 660-668, 2015 | 305 | 2015 |
| Nitrite reductase and nitric-oxide synthase activity of the mitochondrial molybdopterin enzymes mARC1 and mARC2 CE Sparacino-Watkins, J Tejero, B Sun, MC Gauthier, J Thomas, ... Journal of Biological Chemistry 289 (15), 10345-10358, 2014 | 192 | 2014 |
| Expression of SARS-CoV-2 receptor ACE2 and coincident host response signature varies by asthma inflammatory phenotype M Camiolo, M Gauthier, N Kaminski, A Ray, SE Wenzel Journal of Allergy and Clinical Immunology 146 (2), 315-324. e7, 2020 | 116 | 2020 |
| Severe asthma in humans and mouse model suggests a CXCL10 signature underlies corticosteroid-resistant Th1 bias M Gauthier, K Chakraborty, TB Oriss, M Raundhal, S Das, J Chen, R Huff, ... JCI insight 2 (13), 2017 | 112 | 2017 |
| Are we meeting the promise of endotypes and precision medicine in asthma? A Ray, M Camiolo, A Fitzpatrick, M Gauthier, SE Wenzel Physiological reviews 100 (3), 983-1017, 2020 | 99 | 2020 |
| IRF5 distinguishes severe asthma in humans and drives Th1 phenotype and airway hyperreactivity in mice TB Oriss, M Raundhal, C Morse, RE Huff, S Das, R Hannum, MC Gauthier, ... JCI insight 2 (10), e91019, 2017 | 83 | 2017 |
| Clinical outcomes and mortality impact of hyperbaric oxygen therapy in patients with carbon monoxide poisoning JJ Rose, M Nouraie, MC Gauthier, AF Pizon, MI Saul, MP Donahoe, ... Critical care medicine 46 (7), e649-e655, 2018 | 59 | 2018 |
| The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: an overview of network organization, procedures, and interventions SN Georas, RJ Wright, A Ivanova, E Israel, LM LaVange, P Akuthota, ... Journal of Allergy and Clinical Immunology 149 (2), 488-516. e9, 2022 | 48 | 2022 |
| CCL5 is a potential bridge between type 1 and type 2 inflammation in asthma M Gauthier, SL Kale, TB Oriss, M Gorry, RP Ramonell, K Dalton, P Ray, ... Journal of Allergy and Clinical Immunology 152 (1), 94-106. e12, 2023 | 45 | 2023 |
| Dual role for CXCR3 and CCR5 in asthmatic type 1 inflammation M Gauthier, SL Kale, TB Oriss, K Scholl, S Das, H Yuan, S Hu, J Chen, ... Journal of Allergy and Clinical Immunology 149 (1), 113-124. e7, 2022 | 32 | 2022 |
| COVID-19 and the early-career physician-scientist. Fostering resilience beyond the pandemic CR Kliment, IJ Barbash, JS Brenner, D Chandra, K Courtright, ... ATS scholar 2 (1), 19-28, 2021 | 25 | 2021 |
| Immune responses and exacerbations in severe asthma MJ Camiolo, SL Kale, TB Oriss, M Gauthier, A Ray Current opinion in immunology 72, 34-42, 2021 | 17 | 2021 |
| As-needed β agonist-inhaled corticosteroid in mild asthma M Gauthier, SE Wenzel The Lancet 394 (10202), 897-898, 2019 | 3 | 2019 |
| Is it asthma? Recognizing asthma mimics MC Gauthier, ML Fajt Difficult To Treat Asthma: Clinical Essentials, 25-38, 2019 | 3 | 2019 |
| STAT1 and glucocorticoid receptor interaction: mechanism for steroid insensitivity in type 1 high severe asthma M Gauthier, K Chakraborty, TB Oriss, P Ray, S Wenzel, A Ray Journal of Allergy and Clinical Immunology 141 (2), AB196, 2018 | 3 | 2018 |
| Asthma severity and corticosteroid response depend on variable type 1 and type 2 inflammation in the airway JV Fahy, ND Jackson, SP Sajuthi, E Pruesse, CM Moore, JL Everman, ... medRxiv, 2023.10. 05.23296609, 2023 | 2 | 2023 |
| A Potential Mechanism for Steroid Resistance in Severe Asthma M Gauthier, T Oriss, M Raundhal, C Morse, SE Wenzel, P Ray, A Ray A31. ASTHMA THERAPY: GLUCOCORTICOIDS AND BEYOND, A7771-A7771, 2016 | 2 | 2016 |
| P74: Novel human mitochondrial enzyme can transform nitrite into nitric oxide C Sparacino-Watkins, J Tejero, J Wang, VP Ragireddy, M Gauthier, ... Nitric Oxide 31, S45-S46, 2013 | 2 | 2013 |
| Type 1 immune responses related to viral infection influence corticosteroid response in asthma JV Fahy, ND Jackson, SP Sajuthi, E Pruesse, CM Moore, JL Everman, ... American Journal of Respiratory and Critical Care Medicine 211 (2), 194-204, 2025 | 1 | 2025 |
| Biologic Medications for Severe Asthma: Implications for Understanding Pathogenic Heterogeneity and Endotypes RP Ramonell, MC Gauthier, A Ray, SE Wenzel Annual Review of Medicine 76, 2024 | 1 | 2024 |
